Latest News
Alexion settles lawsuit over patent for anemia treatment
Providence Journal (R.I.), The | 32 minutes ago
Alexion Pharmaceuticals Inc., which has a drug manufacturing plant in Smithfield, has agreed to pay $25 million to PDL BioPharma Inc. to license patents used for Alexion s Soliris anemia treatment, settling a lawsuit over claims that the company infringed the technology.... (more)
Share values of 23 major pharma cos decline by 33% during 2008
Pharmabiz.com (India) | 34 minutes ago
The year 2008 is marked by volatile movements on the stock market with heavy selling pressure by foreign financial institutions and general investors on account of recessionary conditions worldwide. The BSE Healthcare index of 23 major pharmaceutical companies drifted down by 33 per cent to 2966.19 as at the last day of 2008 as compared to 4418.65 points at the end of year 2007. However, the there was small gain across the counters on the first trading day of 2009 with little investors support.... (more)
Biovail settles litigation
Pharmabiz.com (India) | 34 minutes ago
Biovail Corporation announced that a settlement agreement has been reached to resolve all outstanding litigation involving former Banc of America Securities analyst Jerry I Treppel, including all claims asserted against the company by Treppel, and all claims by and against each of Eugene Melnyk and Treppel. The litigation originally commenced in April 2003.... (more)
Endo Will Buy Indevus in $637 Million Deal
Wall Street Journal, The | 2 hours 57 minutes ago
... (more)
Bayer filed patent for iPS in 2007
Japan Times | 3 hours 44 minutes ago
German chemical giant Bayer AG applied for a patent in Japan on June 15, 2007, for a technique to generate induced pluripotent stem cells, or iPS cells, from human cells, according to Patent Office data. The application was submitted around three months before a team led by Kyoto University professor Shinya Yamanaka announced the successful generation of iPS cells from human cells. If the patents are granted to Bayer, patent rights will become complicated and could affect the gove...... (more)
Premarket roundup: Family Dollar, Pfizer
Boston Globe, The | 5 hours 43 minutes ago
Among the premarket stories for Monday, Jan. 5, from AP Financial News:... (more)
Sanofi-Aventis spent $1.8M lobbying in 3Q
Boston Globe, The | 5 hours 43 minutes ago
WASHINGTON—Two U.S. subsidiaries of the world's No. 4 drugmaker, Sanofi-Aventis SA of France, spent more than $1.8 million in the third quarter to lobby the federal government, according to recent disclosure forms.... (more)
Biogen shares fall on JP Morgan downgrade
Boston Globe, The | 5 hours 43 minutes ago
NEW YORK—Shares of Biogen Idec Inc. fell Monday after JP Morgan cut its rating on the stock, saying the multiple sclerosis drug Tysabri could continue facing challenges in 2009 while the company lacks any catalysts to drive new revenue.... (more)
The Science Business by Matthew Herper
Forbes | 8 hours 24 minutes ago
The New York Times has a wonderful piece this morning about the use of misoprostol, a generic drug, to induce at-home abortion among pregnant Dominican women. The article cites two recent surveys conducted by medical researchers, the first in New York, Boston, and San Francisco, and the second in New York and Santo Domingo. The article does a great job summarizing the medical risks of the approach and other ways of attempting to end an unwanted pregnancy, including throwing themselves down st...... (more)
PDL BioPharma, Alexion settle patent dispute
Boston Globe, The | 11 hours 42 minutes ago
NEW YORK—PDL BioPharma Inc. and Alexion Pharmaceuticals Inc. said Monday they settled a patent dispute over the blood disorder drug Soliris, in a cash for rights exchange.... (more)
PPD buys lab, hires 80 from Merck
American City Business Journals | 11 hours 43 minutes ago
PPD has purchased a state-of-the-art laboratory and hired 80 employees from Merck as part of a vaccine-testing agreement announced Monday.... (more)
SciClone investor seeking control of the board
American City Business Journals | 11 hours 43 minutes ago
SciClone Pharmaceuticals Inc. said Monday that an investor, Defiante Farmaceutica S.A., plans to nominate four candidates for the company's seven-member board.... (more)
Report: Pfizer open to buying competitors
American City Business Journals | 11 hours 44 minutes ago
Pfizer Inc. told the Financial Times on Monday that it is willing to buy a competitor in order to grow revenue.... (more)
36 Stories | 
RSS Feed
Sign up for BIO SmartBrief
Latest Blog Postsview more
Business of Biotech Conference At Moffitt Cancer Center
BioTech Weblog, The
Volcanoes cool the tropics
Science Blog
Doubts make consumers more willing to reevaluate brands
Science Blog
Stars forming just beyond black hole
Science Blog
Companies in the news
- Alexion Pharmaceuticals
- Alpharma Inc
- Baxter International Inc
- Bayer Healthcare L.L.C
- CSL Limited
- Dow Pharmaceutical Sciences Inc.
- GPC
- Genentech Inc
- GlaxoSmithKline plc
- Merck & Co Inc
- Mylan Pharmaceuticals Inc
- Novartis
- Pfizer
- Ranbaxy Laboratories
- Sandoz Inc